These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9464547)

  • 1. Synergistic transcriptional activation of the MCK promoter by p53: tetramers link separated DNA response elements by DNA looping.
    Jackson P; Mastrangelo I; Reed M; Tegtmeyer P; Yardley G; Barrett J
    Oncogene; 1998 Jan; 16(2):283-92. PubMed ID: 9464547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription.
    Zhao J; Schmieg FI; Logsdon N; Freedman D; Simmons DT; Molloy GR
    Oncogene; 1996 Jul; 13(2):293-302. PubMed ID: 8710368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
    Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
    Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct distal and proximal p53-binding sites in the MCK promoter govern the transcriptional response to p53.
    Jackson P; Yardley G
    FEBS Lett; 1997 Apr; 406(3):271-4. PubMed ID: 9136900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-dependent activation of the mouse MCK gene promoter: identification of a novel p53-responsive sequence and evidence for cooperation between distinct p53 binding sites.
    Jackson P; Shield M; Buskin J; Hawkes S; Reed M; Perrem K; Hauschka SD; Braithwaite A
    Gene Expr; 1995; 5(1):19-33. PubMed ID: 7488858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes.
    Thornborrow EC; Patel S; Mastropietro AE; Schwartzfarb EM; Manfredi JJ
    Oncogene; 2002 Feb; 21(7):990-9. PubMed ID: 11850816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene.
    Tamir Y; Bengal E
    Oncogene; 1998 Jul; 17(3):347-56. PubMed ID: 9690516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a DNA element that can enhance p53-mediated transactivation.
    Shiio Y; Yamamoto T; Yamaguchi N
    Oncogene; 1993 Aug; 8(8):2059-65. PubMed ID: 8393159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UV responsive elements in the human mimecan promoter: a functional characterization.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay.
    Inga A; Monti P; Fronza G; Darden T; Resnick MA
    Oncogene; 2001 Jan; 20(4):501-13. PubMed ID: 11313981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
    Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
    Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed evolution of p53 variants with altered DNA-binding specificities by in vitro compartmentalization.
    Fen CX; Coomber DW; Lane DP; Ghadessy FJ
    J Mol Biol; 2007 Aug; 371(5):1238-48. PubMed ID: 17610896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-type- and promoter-dependent ts phenotype of p53 Val135.
    Sehgal PB; Margulies L
    Oncogene; 1993 Dec; 8(12):3417-9. PubMed ID: 8247545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a p53-response element in the promoter of the proline oxidase gene.
    Maxwell SA; Kochevar GJ
    Biochem Biophys Res Commun; 2008 May; 369(2):308-13. PubMed ID: 18279664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
    Zeng PY; Berger SL
    Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of p53-mediated transcriptional responses by mithramycin A.
    Koutsodontis G; Kardassis D
    Oncogene; 2004 Dec; 23(57):9190-200. PubMed ID: 15489892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UV radiation is a transcriptional inducer of p21(Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner.
    Haapajärvi T; Kivinen L; Heiskanen A; des Bordes C; Datto MB; Wang XF; Laiho M
    Exp Cell Res; 1999 Apr; 248(1):272-9. PubMed ID: 10094833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation.
    Takahashi S; Saito S; Ohtani N; Sakai T
    Cancer Res; 2001 Feb; 61(3):1187-95. PubMed ID: 11221850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.